Recent News

• 04.24.2025 - Bio-Techne Announces Early Access Program for Next-Generation Spatial Protein Proximity Detection
• 04.23.2025 - Bio-Techne to Showcase Cutting-Edge Solutions at the 2025 American Association for Cancer Research (AACR) Annual Meeting
• 04.15.2025 - Bio-Techne to Host Conference Call on May 7, 2025, to Announce Third Quarter Fiscal 2025 Financial Results
• 04.02.2025 - Leica Biosystems and Bio-Techne Expand Partnership to Enable Protease-Free Workflows for Automated Spatial Multiomics on the BOND RX Research Staining Instrument
• 03.26.2025 - Bio-Techne Announces New Customer Experience Centre in Düsseldorf, Germany
• 03.24.2025 - Bio-Techne to Highlight Advances in the Detection of Clinically Relevant Biomarkers using RNAscope Technologies at the 2025 USCAP Annual Meeting
• 03.10.2025 - Bio-Techne Begins Shipping Leo - A Next Generation High-Throughput Simple Western System
• 03.03.2025 - Bio-Techne Launches New Panel Resolving Hard-to-Decipher Carrier Screening Genes
• 02.27.2025 - Bio-Techne to Present at Investor Conferences
• 02.20.2025 - Bio-Techne Launches Expanded Menu of RNAscope Probes for Human and Mouse Transcriptome to Advance Spatial Biology

Recent Filings

• 04.11.2025 - 4/A Statement of changes in beneficial ownership of securities
• 04.07.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.04.2025 - 8-K Current report
• 02.18.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.14.2025 - 144 Report of proposed sale of securities
• 02.07.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.07.2025 - 3 Initial statement of beneficial ownership of securities
• 02.06.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]